| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |